AWM
INFI

AE Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

AE Wealth Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,559
Closed -$16K – 1935
2022
Q3 		$16K Buy
+13,559
New +$14.6K ﹤0.01% 1717

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

AE Wealth Management's INFI Position: Q4 2022 in Review

AE Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 13,559 shares — an estimated $16K sold.

AE Wealth Management first reported a position in INFI in Q3 2022 and held it in 1 quarter. The position peaked at $16K in Q3 2022. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • AE Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • AE Wealth Management sold 13,559 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $16K.
  • AE Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • AE Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $16K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on AE Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.